Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03832283 · ClinicalTrials.gov registry record · NA
Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-Depression
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 4,161
- Enrollment target
NCT03832283: Completed NA study, sponsored by University of Chicago.
NCT03832283 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 4,161 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (196% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03832283, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,161 participants
- Enrollment target
Study Summary
Currently, very little research exists on whether patient portals could be used to integrate patient-reported outcome (PRO) measurement into the electronic health record (EHR) and clinical practice, even though 87% of ambulatory care practices have EHRs and 88% of U.S. adults have access to the internet. To date, no randomized controlled trial has examined whether patient portals can be used to collect PRO measures. The goal of this study is to implement the integration of a computerized adaptive test (CAT) for patient-reported outcome (PRO) measurement of depression symptoms into an electronic health record (EHR) and evaluate the effectiveness of collecting CAT PROs via an EHR patient portal in two randomized controlled trials. This study will advance the science of implementation of patient-centered outcomes research into clinical practice, as well as the evidence for high quality, accessible care.
Interventions
- DIAGNOSTIC_TEST CAD-MDD/CAT-DI screening via MyChart
- DIAGNOSTIC_TEST CAD-MDD/CAT-DI screening during clinic visit
- OTHER CAT-DI monitoring via MyChart
- OTHER PHQ-9 monitoring during clinic visits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,161 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-03-01 |
| Phase | NA |
What the finished NCT03832283 record still lists
NCT03832283 is an interventional study that assigns participants to a tested intervention. Its 4,161 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (196% higher).
The record links to 0 conditions, and to 4 interventions - of which CAD-MDD/CAT-DI screening via MyChart is the first listed.
NCT03832283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03832283 about?
NCT03832283 is a clinical study titled "Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-Depression". Currently, very little research exists on whether patient portals could be used to integrate patient-reported outcome (PRO) measurement into the electronic health record (EHR) and clinical practice, even though 87% of ambulatory care practices have EHRs and 88% of U.S. adults have access to the inte...
What is the current status of trial NCT03832283?
This trial is currently completed. It is a NA study. The enrollment target is 4,161 participants. The study started on 2019-05-01. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT03832283?
The interventions under investigation include: CAD-MDD/CAT-DI screening via MyChart (DIAGNOSTIC_TEST), CAD-MDD/CAT-DI screening during clinic visit (DIAGNOSTIC_TEST), CAT-DI monitoring via MyChart (OTHER), PHQ-9 monitoring during clinic visits (OTHER).
Who is sponsoring clinical trial NCT03832283?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03832283's enrollment target sits among peer trials
4,161 32nd of 2000 higher than 1,969 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI